Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Garoushi, Sabri; Johnson, Mark I.; Tashani, Osama A.

doi:10.1080/19932820.2017.1384288

Cited by 9 publications

(11 citation statements)

References 21 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study estimated that 42.2% of individuals with diabetes in Eastern Libya had probable PDN, based on a S-LANSS score of ≥12. This estimate is similar to our pilot study that found that 41.3% of 109 individuals with diabetes had probable PDN [19]. The estimate is similar to the findings of our systematic review that estimated the prevalence of PDN in individuals with diabetes in the MENA region to be 43.2%, (95% CI = 30.1–57.2%, eight surveys, 7806 participants, 3761 women) [16].…”

Section: Discussionsupporting

confidence: 88%

“…Recently, we conducted a search of research databases and failed to find any epidemiological studies estimating the prevalence of PDN in Libya. Previously we have translated the LANSS pain scale and the self-report version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) into Arabic and found both instruments to be valid and reliable to screen for neuropathic pain in a sample of adults with diabetes living in Libya [19]. We estimated the prevalence of PDN to be 41.3%, but expressed caution at this finding because it was derived from a small sample of 109 adult patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya

Garoushi¹,

Johnson²,

Tashani³

2019

BMC Public Health

Self Cite

View full text Add to dashboard Cite

BackgroundPainful Diabetic Neuropathy (PDN) is a complication that affects up to one third of people living with diabetes. There is limited data on the prevalence of PDN from countries in the Middle East and North Africa. The aim of this study was to estimate the point prevalence of PDN in adults in Eastern Libya using the self-report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale.MethodsWe invited patients attending the Benghazi Diabetes Centre who had diabetes for ≥ 5 years to take part in the study. Patients provided consent and completed the Arabic S-LANSS. Anthropometrics, marital status, socioeconomic and education information was recoded and fasting plasma glucose concentration determined.ResultsFour hundred and fifty participants completed the study (age = 19 to 87 years, BMI = 17.6 to 44.2 kg/m2, 224 women). One hundred and ninety five participants (43.3%) reported pain in their lower limbs in the previous 6 months and 190/195 participants (97.4%) reported a S-LANSS score of ≥ 12 suggesting they had neuropathic pain characteristics. Thus, 42.2% (190/450) of participants with diabetes were categorised as experiencing pain with neuropathic characteristics. Mean ± SD duration of diabetes for participants with PDN (20.4 ± 6.5 years) was significantly higher compared with those without PDN (11.1 ± 4.6 years). Participants with PDN smoked tobacco for more years than those without pain (7.9 ± 12.3 years versus 1.1 ± 3.9 years respectively); had significantly higher fasting plasma glucose concentration (143.6 ± 29.3 mg/dl versus 120.0 ± 17.3 mg/dl) and had a significantly higher levels of education and employment status. The most significant predictors of PDN were duration of diabetes (OR = 25.85, 95% CI = 13.56–49.31), followed by smoking for men (OR = 8.28, 95% CI = 3.53–9.42), obesity (OR = 3.96, 95% CI = 2.25–6.96) and high fasting plasma glucose concentration (OR = 3.51, 95% CI = 1.99–6.21).ConclusionThe prevalence of PDN in people with diabetes in Eastern Libya was 42.2%. Risk factors for developing PDN were high fasting plasma glucose concentration, long duration of diabetes, and higher level of educational and employment status.Electronic supplementary materialThe online version of this article (10.1186/s12889-018-6374-9) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Introductionmentioning

confidence: 99%

A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya

Garoushi¹,

Johnson²,

Tashani³

2019

BMC Public Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…Three independently-trained doctors assessed the nerve and mental conditions of the patients in accordance with the pain symptoms and neurological signs: i) The visual analogue scale (VAS) ( 12 , 14 ); ii) the Toronto Clinical Scoring System (TCSS) ( 12 , 14 ); and iii) the Leeds Assessment of Neuropathic Symptoms and Signs ( 12 , 15 ).…”

Section: Methodsmentioning

confidence: 99%

Increased thalamo‑cortical functional connectivity in patients with diabetic painful neuropathy: A resting‑state functional MRI study

Liu

Mao

et al. 2021

Exp Ther Med

View full text Add to dashboard Cite

Functional changes in the brain of patients with painful diabetic neuropathy (PDN) have remained largely elusive. The aim of the present study was to explore changes in thalamo-cortical functional connectivity (FC) of patients with PDN using resting-state functional MRI. A total of 20 patients with type 2 diabetes mellitus (T2DM) with non-painful diabetic neuropathy (Group NDN), 19 patients with T2DM with PDN (Group-PDN) and 13 age-, sex- and education-matched healthy controls were recruited. The differences in thalamo-cortical FC among the three groups were compared. Patients in Group PDN had increased FC in the left thalamus, the right angular gyrus and the occipital gyrus as compared to those in Group NDN. Furthermore, patients in Group PDN had increased FC in the right thalamus and angular gyrus as compared to those in Group NDN. In conclusion, the present results suggested that the thalamo-cortical FC is increased in patients with T2DM and PDN. Furthermore, the increased FC in the thalamic-parietal-occipital connectivity may be a central pathophysiological mechanism for PDN. The study was retrospectively registered at ClinicalTrials.gov on 3 October 2018 (identifier no. NCT03700502).

show abstract

“…There are four chronic pain measurement tools that have been translated into Arabic and have been used: the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) (Garoushi et al, 2017), Pain Catastrophizing Scale (PCS) (Huijer et al, 2017), IDentification Pain questionnaire (ID‐P) (Abu‐Shaheen et al, 2018), short‐form McGill Pain Questionnaire (SF‐MPQ) (Terkawi et al, 2017), and Brief Pain Inventory (BPI) (Ballout et al, 2011). However, both the LANSS and ID‐P specifically differentiate between neuropathic and nonneuropathic pain, and the PCS assesses the psychological features of chronic pain without assessing persistent pain multidimensionality.…”

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%

Evaluation of the Arabic version of the Chronic Pain Grade scale: Psychometric properties

Alhalal

Jackson

2021

Research in Nursing & Health

View full text Add to dashboard Cite

To increase our understanding of chronic pain in clinical and research contexts, an assessment of its dimensions using reliable and valid self‐reported pain measures is imperative. However, well‐validated Arabic chronic pain assessment scales are lacking. The Chronic Pain Grade (CPG) scale has been used worldwide, yet an Arabic version of the CPG scale has not yet been validated. Thus, we conducted this study to demonstrate the psychometric properties, including reliability, convergent validity, and construct validity of the Arabic CPG scale. A cross‐sectional study was conducted in two hospitals in Saudi Arabia. Data were collected from a convenience sample of 233 chronic pain patients. The confirmatory factor analysis showed an excellent fit with the factor structure of the CPG scale and, thus, supported construct validity. The two identified subscales were pain intensity and pain disability. Convergent validity was supported by having significant correlations between the short‐form McGill Pain Questionnaire and CPG subscales. Internal consistency reliability was demonstrated, as Cronbach's α was 0.916 for pain intensity and 0.815 for pain disability. This study provides evidence that the Arabic CPG scale is a reliable and valid measure of chronic pain dimensions, including pain intensity, and pain‐related disability. This Arabic version of the CPG scale has the potential to expand research and clinical assessment in the Arab world. Future studies are required for further validation.

show abstract

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Cited by 9 publications

References 21 publications

A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya

A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya

Increased thalamo‑cortical functional connectivity in patients with diabetic painful neuropathy: A resting‑state functional MRI study

Evaluation of the Arabic version of the Chronic Pain Grade scale: Psychometric properties

Contact Info

Product

Resources

About